医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
17期
13-14
,共2页
脑卒中%舒肝解郁胶囊%艾司西酞普兰%卒中后抑郁
腦卒中%舒肝解鬱膠囊%艾司西酞普蘭%卒中後抑鬱
뇌졸중%서간해욱효낭%애사서태보란%졸중후억욱
Stroke%The liver resolve depression capsule%Escitalopram citalopram%Poststroke depression
目的:观察舒肝解郁胶囊联合艾司西酞普兰治疗老年脑卒中后抑郁障碍的临床疗效。方法:将120例老年脑卒中后抑郁障碍患者随机分为对照组n=60,单纯艾司西酞普兰治疗;联合组n=60,在艾司西酞普兰治疗基础上加服舒肝解郁胶囊8周为1个疗程,观察比较两组患者治疗前后症状改善情况。结果:经8周治疗两组症状均有改善,与治疗前比较差异有统计学意义(P<0.05);联合组疗效优于对照组(P<0.05)。结论:舒肝解郁胶囊联合艾司西酞普兰治疗老年脑卒中后抑郁障碍疗效确切。
目的:觀察舒肝解鬱膠囊聯閤艾司西酞普蘭治療老年腦卒中後抑鬱障礙的臨床療效。方法:將120例老年腦卒中後抑鬱障礙患者隨機分為對照組n=60,單純艾司西酞普蘭治療;聯閤組n=60,在艾司西酞普蘭治療基礎上加服舒肝解鬱膠囊8週為1箇療程,觀察比較兩組患者治療前後癥狀改善情況。結果:經8週治療兩組癥狀均有改善,與治療前比較差異有統計學意義(P<0.05);聯閤組療效優于對照組(P<0.05)。結論:舒肝解鬱膠囊聯閤艾司西酞普蘭治療老年腦卒中後抑鬱障礙療效確切。
목적:관찰서간해욱효낭연합애사서태보란치료노년뇌졸중후억욱장애적림상료효。방법:장120례노년뇌졸중후억욱장애환자수궤분위대조조n=60,단순애사서태보란치료;연합조n=60,재애사서태보란치료기출상가복서간해욱효낭8주위1개료정,관찰비교량조환자치료전후증상개선정황。결과:경8주치료량조증상균유개선,여치료전비교차이유통계학의의(P<0.05);연합조료효우우대조조(P<0.05)。결론:서간해욱효낭연합애사서태보란치료노년뇌졸중후억욱장애료효학절。
Objective To observe the liver resolve depression capsule combined escitalopram citalopram treatment the clinical curative effect of senile depressive disorder after stroke. Methods To 120 cases of senile patients with depressive disorder after stroke were randomly divided into the control group, n=60 ChanChunYi department of citalopram treatment;N=60 joint group, on the basis of escitalopram citalopram treatment and taking the liver resolve depression capsule eight weeks for a period of treatment, comparing two groups before and after treatment in patients with symptoms was observed. Results After 8 weeks treatment symptoms were improved in both groups, the difference was statistically significant compared with before treatment (P<0.05);Combined treatment group is better than that of control group (P<0.05). Conclusions The liver capsule joint resolve depression escitalopram citalopram treatment of elderly depressive disorder after stroke curative effect.